Covetrus (CVET), a global leader in animal-health technology and services, announced today that it will release first quarter 2020 financial results after the market close on Thursday, May 14, 2020. The company will hold a conference call at 4:30 PM ET the same day. During the call, Ben Wolin, president and chief executive officer, and Stuart B. Gleichenhaus, interim chief financial officer, will review the financial results and provide a business update.
Operationally, all of the company's distribution centers and pharmacies currently remain open, as veterinary medicine has been deemed an essential service in most geographies.
Covetrus (CVET), a global leader in animal-health technology and services, announced today a $250 million investment from Clayton, Dubilier & Rice (CD&R), a leading private investment firm that has been a significant shareholder of the Company since its formation in 2019 and formerly of its predecessor company, Vets First Choice, since 2015. This additional capital significantly strengthens the Company’s financial profile and enables management to execute against strategic growth objectives.
Covetrus announced three additions to its senior leadership team: global CFO, president of its N.A. American distribution, and global CIO.
Covetrus (CVET) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Covetrus announced that it has completed the sale of its scil animal care business to Heska Corporation.
Covetrus (CVET) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, today announces the completion of the acquisition of scil animal care company GmbH ("scil") from Covetrus, Inc. for US $110 million in cash, subject to customary closing adjustments (NASDAQ: CVET; "Covetrus") (the "Acquisition"). The Acquisition, which was first announced on January 14, 2020, represents a key milestone in the Company's long-term strategic plan. scil has been a proven European leader since 1998 in providing veterinary point-of-care laboratory and imaging diagnostics, with headquarters in Germany and operations in France, Italy, Spain and Canada. This acquisition creates a leading global veterinary diagnostics company, servicing millions of pets through tens of thousands of veterinarians and active point of care analyzers around the world. Through this combination, Heska expects to1:
Here we take a sneak peek at four tech stocks lined up to report quarterly earnings on May 14.
Covetrus is embedding secure video teleconferencing capabilities across the company’s global suite of PIMS, and prescription management.
Covetrus (CVET) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Good afternoon, and thank you for joining us for Covetrus's Q1 2020 Earnings Call. Joining me on today's call are Ben Wolin, our President and Chief Executive Officer, and Stuart Gleichenhaus, our Interim Chief Financial Officer.
Hedge funds don't get the respect they used to get. Nowadays investors prefer passive funds over actively managed funds. One thing they don't realize is that 100% of the passive funds didn't see the coronavirus recession coming, but a lot of hedge funds did. Even we published an article near the end of February and […]
First quarter GAAP net sales of $1.07 billion, an increase of 13% year-over-year; non-GAAP pro forma organic net sales increased 10% year-over-year First quarter GAAP net loss.
Covetrus (CVET) delivered earnings and revenue surprises of -5.56% and -0.27%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Silver Ring Value Partners LP is a Boston-based investment management firm that specializes in delivering long-term value by utilizing an intrinsic and robust approach to investing. The company was founded in 2016 by Chief Investment Officer and Managing Partner Gary Mishuris. Recently, Silver Ring Value Partners released its Q1 2020 Investor Letter – a copy […]
Coronavirus-triggered supply-chain disruptions are likely to have dampened Danaos' (DAC) Q1 performance.
The value investor's first quarter of 2020 Continue reading...
As of late, it has definitely been a great time to be an investor in Covetrus.
Credit Suisse (SIX:CSGN) analyst Erin Wright maintained a Hold rating on Covetrus (NASDAQ:CVET) Inc on Thursday, setting a price target of $10, which is approximately 17.90% below the present share price of $12.18.